Allogene Therapeutics, Inc. — Investor Relations & Filings
Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies. The company engineers T cells from healthy donors to create "off-the-shelf" treatments for cancer and autoimmune diseases. This approach is designed to enable on-demand availability, scalability, and reliability, contrasting with autologous therapies that use a patient's own cells. Allogene's pipeline utilizes multiplex gene-engineering and gene-editing capabilities. Its key investigational programs include cemacabtagene ansegedleucel (cema-cel) for large B-cell lymphoma, ALLO-316 for clear cell renal cell carcinoma, and ALLO-329 for autoimmune disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFA14A | 2026-05-28 | English | |
| 8-K | 2026-05-28 | English | |
| DEFA14A | 2026-05-20 | English | |
| 8-K - Allogene Therapeutics, Inc. (0001737287) (Filer) | 2026-05-13 | English | |
| 424B5 - Allogene Therapeutics, Inc. (0001737287) (Filer) | 2026-04-15 | English | |
| 424B5 - Allogene Therapeutics, Inc. (0001737287) (Filer) | 2026-04-13 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47868448 | DEFA14A | 2026-05-28 | English | ||
| 47868481 | 8-K | 2026-05-28 | English | ||
| 46726629 | DEFA14A | 2026-05-20 | English | ||
| 45762022 | 8-K - Allogene Therapeutics, Inc. (0001737287) (Filer) | 2026-05-13 | English | ||
| 34609865 | 424B5 - Allogene Therapeutics, Inc. (0001737287) (Filer) | 2026-04-15 | English | ||
| 34439500 | 424B5 - Allogene Therapeutics, Inc. (0001737287) (Filer) | 2026-04-13 | English | ||
| 34434910 | 8-K - Allogene Therapeutics, Inc. (0001737287) (Filer) | 2026-04-13 | English | ||
| 34409554 | 8-K - Allogene Therapeutics, Inc. (0001737287) (Filer) | 2026-04-13 | English | ||
| 32897513 | 4 - ALLOGENE THERAPEUTICS, INC. (0001737287) (Filer) | 2026-03-04 | English | ||
| 31528502 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31528553 | 4 Filing | 2026-02-04 | English | ||
| 31528550 | 4 Filing | 2026-02-04 | English | ||
| 31528532 | 4 Filing | 2026-02-04 | English | ||
| 31528520 | 4 Filing | 2026-02-04 | English | ||
| 31528515 | 4 Filing | 2026-02-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
eureKING
A SPAC created to acquire European biomanufacturing compani…
|
KINGS | FR | Manufacturing |
|
EuroAPI
Develops and manufactures APIs and provides CDMO services f…
|
EAPI | FR | Manufacturing |
|
Eurobio Scientific
Specializes in in vitro diagnostics for transplantation, on…
|
ALERS | FR | Manufacturing |
|
EUROFARMA LABORATÓRIOS S.A.
Multinational pharmaceutical firm specializing in R&D and m…
|
— | BR | Manufacturing |
|
European Institute of Science AB
Develops and sells diagnostic solutions and instruments for…
|
EURI B | SE | Manufacturing |
|
Eutilex Co.,Ltd.
Develops immunotherapeutics for cancers and autoimmune dise…
|
263050 | KR | Manufacturing |
|
Everest Medicines Limited
Biopharma company developing and commercializing products t…
|
1952 | KY | Manufacturing |
|
Everest Organics Ltd.
Integrated manufacturer of APIs and bulk drug intermediates…
|
524790 | IN | Manufacturing |
|
Evoke Pharma Inc
A specialty pharma company developing drugs for gastrointes…
|
EVOK | US | Manufacturing |
|
Evolus, Inc.
A performance beauty company developing neurotoxins and der…
|
EOLS | US | Manufacturing |
Allogene Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33378/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33378 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33378 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33378 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33378}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Allogene Therapeutics, Inc. (id: 33378)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.